Nontuberculous mycobacterium seroprevalence in Japanese patients with RA
Yusuke Yano, Shinichi Nogi, Hirokazu Taguchi, Takashi Higuchi, Fuminori Hirano, Shomi Oka, Kota Shimada, Toshihiro Matsui, Shigeto Tohma, Kenji Itoh, Hiroshi Furukawa · 2026
Read Nontuberculous mycobacterium seroprevalence in Japanese patients with RA by Yusuke Yano, Shinichi Nogi, Hirokazu Taguchi, Takashi Higuchi, Fuminori Hirano, Shomi Oka, Kota Shimada, Toshihiro Matsui, Shigeto Tohma, Kenji Itoh, Hiroshi Furukawa (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13613127.txt.
Description
Yusuke Yano and co-authors measure how often Japanese patients with rheumatoid arthritis test positive for nontuberculous mycobacteria exposure. New immune-suppressing drugs control the disease well but raise infection risk, including these mycobacteria and tuberculosis. A blood test for antibodies against one bacterial coating is used to screen for the first threat.
Their 2026 study reviews test records gathered over about a decade at their centers. Antibody test positivity ran higher in women and in older patients, and it rose over time. Younger women also trended upward. By contrast, positivity on the tuberculosis release assay fell over the same years. The authors weigh what the split trends mean for screening.
Catalog record
| CREATOR | Yusuke Yano, Shinichi Nogi, Hirokazu Taguchi, Takashi Higuchi, Fuminori Hirano, Shomi Oka, Kota Shimada, Toshihiro Matsui, Shigeto Tohma, Kenji Itoh, Hiroshi Furukawa |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 22 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |